PL2394638T3 - Nowe połączenia farmaceutyczne - Google Patents
Nowe połączenia farmaceutyczneInfo
- Publication number
- PL2394638T3 PL2394638T3 PL11169599T PL11169599T PL2394638T3 PL 2394638 T3 PL2394638 T3 PL 2394638T3 PL 11169599 T PL11169599 T PL 11169599T PL 11169599 T PL11169599 T PL 11169599T PL 2394638 T3 PL2394638 T3 PL 2394638T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical combinations
- new pharmaceutical
- combinations
- new
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/04754A TR201004754A1 (tr) | 2010-06-11 | 2010-06-11 | Yeni Farmasötik Kombinasyonlar |
| EP11169599.5A EP2394638B1 (en) | 2010-06-11 | 2011-06-10 | New pharmaceutical combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2394638T3 true PL2394638T3 (pl) | 2014-02-28 |
Family
ID=43303905
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11169599T PL2394638T3 (pl) | 2010-06-11 | 2011-06-10 | Nowe połączenia farmaceutyczne |
| PL13150074T PL2586424T3 (pl) | 2010-06-11 | 2011-06-10 | Kompozycje farmaceutyczne zawierające antagonistę receptora angiotensyny II, hydrochlorotiazyd i środek rozsadzający |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13150074T PL2586424T3 (pl) | 2010-06-11 | 2011-06-10 | Kompozycje farmaceutyczne zawierające antagonistę receptora angiotensyny II, hydrochlorotiazyd i środek rozsadzający |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110305757A1 (pl) |
| EP (2) | EP2586424B1 (pl) |
| DK (1) | DK2394638T3 (pl) |
| ES (2) | ES2522873T3 (pl) |
| PL (2) | PL2394638T3 (pl) |
| PT (1) | PT2394638E (pl) |
| TR (1) | TR201004754A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201007508A1 (tr) * | 2010-09-14 | 2012-04-24 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Oral yolla dağılan bileşimler |
| KR101414873B1 (ko) * | 2012-06-28 | 2014-07-03 | 보령제약 주식회사 | 피마살탄 및 히드로클로로티아지드가 함유된 약제학적 조성물 |
| WO2014102628A1 (en) * | 2012-12-31 | 2014-07-03 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition comprising azilsartan medoxomil |
| WO2018019300A1 (zh) * | 2016-07-29 | 2018-02-01 | 武汉朗来科技发展有限公司 | 一种口服固体制剂及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2125251C (en) * | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
| JPH11508894A (ja) * | 1995-06-30 | 1999-08-03 | メルク エンド カンパニー インコーポレーテッド | Ａｃｅ阻害剤とａｉｉ拮抗薬を用いる腎疾患の治療方法 |
| WO2009114648A1 (en) * | 2008-03-11 | 2009-09-17 | Depomed Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| PL2252273T3 (pl) * | 2008-03-19 | 2017-07-31 | Ratiopharm Gmbh | Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny |
| TW201014850A (en) * | 2008-09-25 | 2010-04-16 | Takeda Pharmaceutical | Solid pharmaceutical composition |
-
2010
- 2010-06-11 TR TR2010/04754A patent/TR201004754A1/xx unknown
-
2011
- 2011-06-10 DK DK11169599.5T patent/DK2394638T3/da active
- 2011-06-10 PT PT111695995T patent/PT2394638E/pt unknown
- 2011-06-10 PL PL11169599T patent/PL2394638T3/pl unknown
- 2011-06-10 ES ES13150074.6T patent/ES2522873T3/es active Active
- 2011-06-10 ES ES11169599T patent/ES2424469T3/es active Active
- 2011-06-10 EP EP13150074.6A patent/EP2586424B1/en not_active Not-in-force
- 2011-06-10 EP EP11169599.5A patent/EP2394638B1/en not_active Not-in-force
- 2011-06-10 PL PL13150074T patent/PL2586424T3/pl unknown
- 2011-06-13 US US13/159,049 patent/US20110305757A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT2394638E (pt) | 2013-08-22 |
| EP2586424A1 (en) | 2013-05-01 |
| EP2586424B1 (en) | 2014-08-13 |
| ES2522873T3 (es) | 2014-11-18 |
| US20110305757A1 (en) | 2011-12-15 |
| EP2394638A1 (en) | 2011-12-14 |
| PL2586424T3 (pl) | 2015-03-31 |
| TR201004754A1 (tr) | 2012-01-23 |
| DK2394638T3 (da) | 2013-07-15 |
| EP2394638B1 (en) | 2013-05-08 |
| ES2424469T3 (es) | 2013-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL245326A0 (en) | pharmaceutical preparation | |
| ZA201304158B (en) | Dosage form | |
| PT2619182T (pt) | Composição farmacêutica | |
| IL225457A0 (en) | Pharmaceutical composition | |
| AP2012006640A0 (en) | New aminopyrazoloquinazolines | |
| GB201008005D0 (en) | Pharmaceutical compounds | |
| PT2579858E (pt) | Composição farmacêutica que contém ivabradina | |
| ZA201301920B (en) | Pharmaceutical composition | |
| GB201010453D0 (en) | Pharmaceutical composition | |
| GB201020161D0 (en) | Pharmaceutical compounds | |
| IL221501A (en) | Medicinal product containing miramistine | |
| GB201001911D0 (en) | Pharmaceutical composition | |
| ZA201301851B (en) | Pharmaceutical combinations | |
| IL223324A (en) | Pharmaceutical compounds | |
| PL390620A1 (pl) | Preparat farmaceutyczny | |
| GB201005734D0 (en) | Pharmaceutical compounds | |
| GB201021361D0 (en) | Pharmaceutical Compounds | |
| GB201020365D0 (en) | Pharmaceutical compounds | |
| GB201003950D0 (en) | Pharmaceutical compounds | |
| GB201001216D0 (en) | Pharmaceutical compounds | |
| GB201013968D0 (en) | Pharmaceutical compounds | |
| GB201020364D0 (en) | Pharmaceutical compounds | |
| GB201020366D0 (en) | Pharmaceutical compounds | |
| GB201020068D0 (en) | Pharmaceutical compounds | |
| HUP1000034D0 (en) | Novel pharmaceutical agents |